ivacaftor therapy in patients with cystic fibrosis—a real world study

Overview of attention for article published in Frontiers in Pharmacology, March 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,152 followers.

RT @FrontPharmacol: New Research: Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaf…

08 Mar 2023

Reply Repost Favourite

New Research: Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis—a real world study https://t.co/Y2n1thAvm0 #pharmacology

08 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.